ANIKA THERAPEUTICS INC
10-Q, EX-27, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ANIKA THERAPEUTICS INC, 10-Q, EX-10.2, 2000-11-14
Next: BLANCH E W HOLDINGS INC, 10-Q, 2000-11-14



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                            DEC-31-1999
<PERIOD-START>                               JUL-01-2000
<PERIOD-END>                                 SEP-30-2000
<CASH>                                             5,678
<SECURITIES>                                      12,292
<RECEIVABLES>                                      1,700
<ALLOWANCES>                                           0
<INVENTORY>                                        6,566
<CURRENT-ASSETS>                                  26,846
<PP&E>                                             8,530
<DEPRECIATION>                                    (5,264)
<TOTAL-ASSETS>                                    30,619
<CURRENT-LIABILITIES>                             (6,316)
<BONDS>                                                0
                                  0
                                            0
<COMMON>                                            (100)
<OTHER-SE>                                       (24,203)
<TOTAL-LIABILITY-AND-EQUITY>                     (30,619)
<SALES>                                           (8,919)
<TOTAL-REVENUES>                                  (9,219)
<CGS>                                              6,460
<TOTAL-COSTS>                                      5,808
<OTHER-EXPENSES>                                       0
<LOSS-PROVISION>                                       0
<INTEREST-EXPENSE>                                  (893)
<INCOME-PRETAX>                                   (2,155)
<INCOME-TAX>                                          10
<INCOME-CONTINUING>                               (2,165)
<DISCONTINUED>                                         0
<EXTRAORDINARY>                                        0
<CHANGES>                                              0
<NET-INCOME>                                      (2,165)
<EPS-BASIC>                                        (0.22)
<EPS-DILUTED>                                      (0.22)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission